TODAY'S HEADLINES

Psoriasis drug approved with boxed warning

A new drug to treat moderate-to-severe plaque psoriasis carries a black box warning that suicidal ideas and behavior, including completed suicides, have occurred in patients during the drug's clinical trials. Read more

Popular asthma inhaler now expanded to kids

A leading asthma inhaler will now be available to younger asthma patients, after FDA approved Spiriva Respimat for the long-term, once-daily maintenance treatment of asthma in people aged 6 years and older. Read more

CONTINUING PHARMACY EDUCATION

New options when statins are not enough

This month's CE activity, "New options when statins are not enough," is open for pharmacists and pharmacy technicians.
The goal of this activity is to prepare pharmacists with the knowledge they need to have to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Muscular dystrophy drug launch halts after pricing concerns

Marathon Pharmaceuticals is temporarily pausing the launch of its drug to treat a rare form of muscular dystrophy (MD) after concerns over its $89,000 price tag. Read more

February 22, 2017

Managed Care Pharmacy Survey 2017

Take three minutes to answer our managed care pharmacy survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards. Take survey.

Related Articles

Clear skin within reach for psoriasis patients

Drug maker pays out millions over EpiPen charges